82 related articles for article (PubMed ID: 21252986)
21. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient.
Spencer A; Szydlo RM; Brookes PA; Kaminski E; Rule S; van Rhee F; Ward KN; Hale G; Waldmann H; Hows JM; Batchelor JR; Goldman JM
Blood; 1995 Nov; 86(9):3590-7. PubMed ID: 7579468
[TBL] [Abstract][Full Text] [Related]
22. BCR-ABL fusion peptides and cytotoxic T cells in chronic myeloid leukaemia.
Clark RE; Christmas SE
Leuk Lymphoma; 2001; 42(5):871-80. PubMed ID: 11697642
[TBL] [Abstract][Full Text] [Related]
23. Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein.
Yong AS; Stephens N; Weber G; Li Y; Savani BN; Eniafe R; Keyvanfar K; Kurlander R; Rezvani K; Barrett AJ
Leukemia; 2011 Apr; 25(4):629-37. PubMed ID: 21252986
[TBL] [Abstract][Full Text] [Related]
24. High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide-driven graft-versus-leukemia effects.
Yong AS; Rezvani K; Savani BN; Eniafe R; Mielke S; Goldman JM; Barrett AJ
Blood; 2007 Jul; 110(2):770-5. PubMed ID: 17412886
[TBL] [Abstract][Full Text] [Related]
25. The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens.
Steele JC; Torr EE; Noakes KL; Kalk E; Moss PA; Reynolds GM; Hubscher SG; van Lohuizen M; Adams DH; Young LS
Br J Cancer; 2006 Nov; 95(9):1202-11. PubMed ID: 17024127
[TBL] [Abstract][Full Text] [Related]
26. Graft-versus-leukemia effects of Wilms' tumor 1 protein-specific cytotoxic T lymphocytes in patients with chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
Wang ZD; Li D; Huang XJ
Chin Med J (Engl); 2010 Apr; 123(7):912-6. PubMed ID: 20497687
[TBL] [Abstract][Full Text] [Related]
27. Bmi1 reprograms CML B-lymphoid progenitors to become B-ALL-initiating cells.
Sengupta A; Ficker AM; Dunn SK; Madhu M; Cancelas JA
Blood; 2012 Jan; 119(2):494-502. PubMed ID: 22101899
[TBL] [Abstract][Full Text] [Related]
28. Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation.
Rezvani K; Grube M; Brenchley JM; Sconocchia G; Fujiwara H; Price DA; Gostick E; Yamada K; Melenhorst J; Childs R; Hensel N; Douek DC; Barrett AJ
Blood; 2003 Oct; 102(8):2892-900. PubMed ID: 12829610
[TBL] [Abstract][Full Text] [Related]
29. BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells.
Rizo A; Horton SJ; Olthof S; Dontje B; Ausema A; van Os R; van den Boom V; Vellenga E; de Haan G; Schuringa JJ
Blood; 2010 Nov; 116(22):4621-30. PubMed ID: 20724541
[TBL] [Abstract][Full Text] [Related]
30. Opposing roles of polycomb repressive complexes in hematopoietic stem and progenitor cells.
Majewski IJ; Ritchie ME; Phipson B; Corbin J; Pakusch M; Ebert A; Busslinger M; Koseki H; Hu Y; Smyth GK; Alexander WS; Hilton DJ; Blewitt ME
Blood; 2010 Aug; 116(5):731-9. PubMed ID: 20445021
[TBL] [Abstract][Full Text] [Related]
31. Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens.
Warren EH; Fujii N; Akatsuka Y; Chaney CN; Mito JK; Loeb KR; Gooley TA; Brown ML; Koo KK; Rosinski KV; Ogawa S; Matsubara A; Appelbaum FR; Riddell SR
Blood; 2010 May; 115(19):3869-78. PubMed ID: 20071660
[TBL] [Abstract][Full Text] [Related]
32. Current role of stem cell transplantation in chronic myeloid leukaemia.
Gratwohl A; Heim D
Best Pract Res Clin Haematol; 2009 Sep; 22(3):431-43. PubMed ID: 19959092
[TBL] [Abstract][Full Text] [Related]
33. A gene expression signature of primary resistance to imatinib in chronic myeloid leukemia.
de Lavallade H; Finetti P; Carbuccia N; Khorashad JS; Charbonnier A; Foroni L; Apperley JF; Vey N; Bertucci F; Birnbaum D; Mozziconacci MJ
Leuk Res; 2010 Feb; 34(2):254-7. PubMed ID: 19880181
[TBL] [Abstract][Full Text] [Related]
34. Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis.
Rizo A; Olthof S; Han L; Vellenga E; de Haan G; Schuringa JJ
Blood; 2009 Aug; 114(8):1498-505. PubMed ID: 19556423
[TBL] [Abstract][Full Text] [Related]
35. WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation.
Weber G; Karbach J; Kuçi S; Kreyenberg H; Willasch A; Koscielniak E; Tonn T; Klingebiel T; Wels WS; Jäger E; Bader P
Leukemia; 2009 Sep; 23(9):1634-42. PubMed ID: 19357702
[TBL] [Abstract][Full Text] [Related]
36. CD8+ T-cell responses to tumor-associated antigens correlate with superior relapse-free survival after allo-SCT.
Kapp M; Stevanović S; Fick K; Tan SM; Loeffler J; Opitz A; Tonn T; Stuhler G; Einsele H; Grigoleit GU
Bone Marrow Transplant; 2009 Mar; 43(5):399-410. PubMed ID: 19139738
[TBL] [Abstract][Full Text] [Related]
37. Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia.
Rezvani K; Yong AS; Tawab A; Jafarpour B; Eniafe R; Mielke S; Savani BN; Keyvanfar K; Li Y; Kurlander R; Barrett AJ
Blood; 2009 Mar; 113(10):2245-55. PubMed ID: 18988867
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
